CATALOGO DEI PRODOTTI DELLA RICERCA

Carbone, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.466
EU - Europa 1.365
AS - Asia 725
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
Totale 3.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.460
CN - Cina 455
GB - Regno Unito 414
IT - Italia 249
SG - Singapore 174
SE - Svezia 152
IE - Irlanda 120
DE - Germania 113
RU - Federazione Russa 103
FR - Francia 96
FI - Finlandia 63
VN - Vietnam 33
HK - Hong Kong 23
UA - Ucraina 22
BE - Belgio 12
ID - Indonesia 11
JP - Giappone 11
NL - Olanda 8
KR - Corea 6
AU - Australia 5
CA - Canada 5
TG - Togo 4
TR - Turchia 4
EU - Europa 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
IN - India 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.573
Salva come PNG Salva come JPEG
Città #
Southend 389
Chandler 357
Woodbridge 152
Singapore 144
Ashburn 125
Jacksonville 124
Dublin 120
Verona 88
Beijing 87
Ann Arbor 75
Jinan 52
Wilmington 39
Lawrence 38
Princeton 38
Redmond 37
Helsinki 34
Houston 33
Nanjing 33
Shenyang 32
New York 30
Hebei 24
Tianjin 23
Dong Ket 20
Hong Kong 18
Haikou 15
Taiyuan 15
Nanchang 14
Zhengzhou 14
Sindelfingen 13
Brussels 12
Guangzhou 11
Ningbo 11
Seattle 11
Changsha 10
Jakarta 10
Tokyo 10
Jiaxing 9
Redwood City 9
Boardman 8
Bologna 8
Hangzhou 8
Kent 8
Norwalk 7
Santa Clara 7
Washington 7
Chicago 6
Dallas 5
Fairfield 5
Isola della Scala 5
Los Angeles 5
Munich 5
Nürnberg 5
Seoul 5
Taizhou 5
Cagliari 4
Dearborn 4
Falls Church 4
Fuzhou 4
Lancaster 4
Lanzhou 4
Lomé 4
Milan 4
Rome 4
Clearwater 3
Elora 3
San Francisco 3
Almaty 2
Cattolica 2
Chieti 2
Düsseldorf 2
Giugliano In Campania 2
Glasgow 2
Jeffries 2
Lana 2
Leawood 2
London 2
Melbourne 2
Monza 2
Moscow 2
Quartu Sant'elena 2
Ravello 2
Sydney 2
Toronto 2
Trissino 2
Vienna 2
Villiers-sur-marne 2
Xiangfen 2
Agrigento 1
Auburn Hills 1
Baku 1
Bolzano 1
Boston 1
Bratislava 1
Brno 1
Buccinasco 1
Böblingen 1
Büdelsdorf 1
Cairo 1
Canberra 1
Chaoyang 1
Totale 2.475
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 207
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 148
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 138
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 137
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 120
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 118
NF-κB as a target for pancreatic cancer therapy. 115
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 111
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 111
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 108
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 107
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 106
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 104
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 103
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 103
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 100
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 100
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 99
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 98
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 97
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 91
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 87
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 84
EMT and Treatment Resistance in Pancreatic Cancer 81
Molecular alterations in basal cell carcinoma subtypes 78
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 71
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 70
Toll-Like Receptor 9 Agonists for Cancer Therapy 70
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 68
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 67
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 65
Rationale and clinical use of multitargeting anticancer agents. 63
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 63
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 58
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 50
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 46
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 43
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 39
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 39
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 35
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 17
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 12
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 12
Totale 3.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.914
article - articoli 11.685
book - libri 0
conference - conferenze 827
curatela - curatele 0
other - altro 402
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 0 43 33 41 18 24 39 35 52
2020/2021387 43 33 20 53 42 39 7 8 10 55 34 43
2021/2022436 40 150 17 37 11 5 8 24 9 12 19 104
2022/2023820 70 104 75 149 52 200 4 46 96 7 11 6
2023/2024491 13 22 36 54 52 71 27 77 6 35 73 25
2024/2025377 51 55 51 174 46 0 0 0 0 0 0 0
Totale 3.639